Relmada Therapeutics Inc. (RLMD) Stock Continues Downward Trend Despite Promising Top-line Data from REL-1017 Study
Relmada Therapeutics Inc. (RLMD) stock prices were down 3.26% some time after market trading commenced on July 27th, 2021, bringing the price per share down